{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:02:54Z","timestamp":1781712174621,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jfma.2023.07.019","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T08:15:15Z","timestamp":1691568915000},"page":"1208-1212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Atezolizumab-induced encephalitis with subdural hemorrhage and subarachnoid hemorrhage in a patient with hepatocellular carcinoma"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8191-7923","authenticated-orcid":false,"given":"Ko-Han","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Chung","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2023.07.019_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cld.879","article-title":"Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma","volume":"15","author":"Huppert","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jfma.2023.07.019_bib2","first-page":"2619","article-title":"Atezolizumab-induced encephalitis in a patient with hepatocellular carcinoma: a case report and literature review","volume":"61","author":"Satake","year":"2022"},{"key":"10.1016\/j.jfma.2023.07.019_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial","volume":"389","author":"Rittmeyer","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2023.07.019_bib4","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jfma.2023.07.019_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026377","article-title":"Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: case report and literature review","volume":"100","author":"Ozdirik","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jfma.2023.07.019_bib6","doi-asserted-by":"crossref","first-page":"e847","DOI":"10.1016\/j.clgc.2017.03.001","article-title":"Atezolizumab-induced encephalitis in metastatic bladder cancer: a case report and review of the literature","volume":"15","author":"Levine","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.jfma.2023.07.019_bib7","article-title":"Atezolizumab-related encephalitis in the intensive care unit: case report and review of the literature","volume":"6","author":"Laserna","year":"2018","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.jfma.2023.07.019_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ensci.2018.12.001","article-title":"Atezolizumab-induced encephalitis in metastatic lung cancer: a case report and literature review","volume":"14","author":"Arakawa","year":"2019","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.jfma.2023.07.019_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13256-020-02411-y","article-title":"Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report","volume":"14","author":"Yamaguchi","year":"2020","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jfma.2023.07.019_bib10","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/j.cllc.2020.03.006","article-title":"Immune-related encephalitis in two patients treated with immune checkpoint inhibitor","volume":"21","author":"Robert","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jfma.2023.07.019_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3988\/jcn.2019.15.2.259","article-title":"Immune-checkpoint-inhibitor-induced severe autoimmune encephalitis treated by steroid and intravenous immunoglobulin","volume":"15","author":"Kim","year":"2019","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.jfma.2023.07.019_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3892\/ol.2022.13444","article-title":"Atezolizumab-associated encephalitis in metastatic breast cancer: a case report","volume":"24","author":"Chen","year":"2022","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jfma.2023.07.019_bib13","first-page":"100012","article-title":"Atezolizumab-induced aseptic meningitis in patients with NSCLC","volume":"1","author":"Toyozawa","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jfma.2023.07.019_bib14","doi-asserted-by":"crossref","DOI":"10.4322\/acr.2021.261","article-title":"Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors","volume":"11","author":"Nader","year":"2021","journal-title":"Autops Case Rep"},{"key":"10.1016\/j.jfma.2023.07.019_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000526248","article-title":"Hope, cure, and adverse effects in immunotherapy: atezolizumab-associated encephalitis in metastatic small cell lung cancer - a case report and literature review","volume":"14","author":"Ibrahim","year":"2022","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.jfma.2023.07.019_bib16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00415-013-7234-2","article-title":"The presence of oligoclonal IgG bands in human CSF during the course of neurological diseases","volume":"261","author":"Haertle","year":"2014","journal-title":"J Neurol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623002930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623002930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:50:55Z","timestamp":1760539855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623002930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0929664623002930"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.07.019","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atezolizumab-induced encephalitis with subdural hemorrhage and subarachnoid hemorrhage in a patient with hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}